Theravance Inc (THRX) Q2 2010 Earnings Call April 21, 2010 5:00 pm ET Executives Mike Aguiar - SVP and CFO Rick Winningham - CEO Mathai Mammen - SVP of Research and Early Clinical Development. Analysts Brian Skorney - Thinkequity Llc Jon Stephenson - Summer Street Research Ian Somaiya - Piper Jaffray Brian Bourdot - Barclays Capital. Thomas Russo - Robert W. Baird & Co Howard Liang - Leerink Swann Matt Duffy - BDR Research Operator
At this time I would like to welcome everyone to the Theravance Conference Call to review results for the quarter ended June 30, 2010. (Operator Instructions). Today's conference call is being recorded. Now, I would like to turn the call over to Mike Aguiar, Senior Vice President and Chief Financial Officer. Please go ahead, sir. Mike Aguiar Good afternoon everyone and thank you for joining us. With me on the call today is Rick Winningham, our Chief Executive Officer and Dr. Mathai Mammen, Senior Vice President of Research and Early Clinical Development. Today's call will be in three parts. First, Rick will review highlights from the quarter and he and Dr. Mammen will provide an update on our clinical programs, and then I will review our financial results and finally we will open up the call for questions. Earlier today, Theravance issued a press release detailing second quarter 2010 financial results and recent corporate developments. A copy of the press release can be downloaded from our web site or you can call Investor Relations at 650-808-4100, and we will be happy to assist you. Before we get started, we would like to remind you that this conference call contains forward-looking statements regarding future events and the future performance of Theravance.